Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Actual versus recommended storage temperatures of oral oncolytic drugs at patients' homes

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-E-037-Monday
  • By: VLIELAND, Nicolaas (University Medical Center Utrecht, Laboratory and pharmacy, Utrecht, Netherlands)
  • Co-author(s): Nicolaas Dirk Vlieland: Laboratory and pharmacy, University Medical Center Utrecht, Utrecht, Netherlands
    Bart J van den Bemt: Department of Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands;Department of Pharmacy, Radboud Medical Center, Nijmegen, Netherlands;Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, Netherlands
    Diana A van Riet-Nales: Quality Department, Medicines Evaluation Board, Utrecht, Netherlands
    Marcel L Bouvy: Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
    Toine C Egberts: Laboratory and pharmacy, University Medical Center Utrecht, Utrecht, Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
    Helga Gardarsdottir: Laboratory and pharmacy, University Medical Center Utrecht, Utrecht, Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
    Charlotte Bekker: Laboratory and pharmacy, University Medical Center Utrecht, Utrecht, Netherlands;Department of Pharmacy, Sint Maartenskliniek, Nijmegen,
  • Abstract:

    Backgrounds

    Substantial quantities of unused drugs are returned by patients to the pharmacy each year. Re-dispensing of these drugs would reduce drug wastage and health care costs. However, the quality of drugs stored at home is unknown.

    Aims

    To investigate if home storage temperatures of oral anticancer drugs comply with the manufacturers' Summary

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses